GM Advisory Group LLC Sells 1,311 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• GM Advisory Group LLC has reduced its holdings in UnitedHealth Group by 16.4%, selling 1,311 shares and holding 6,680 shares valued at approximately $3.5 million at the end of the first quarter.
• The healthcare conglomerate recently missed earnings estimates, reporting $4.08 EPS compared to a consensus of $4.45, with a revenue of $111.62 billion for the quarter.
• UnitedHealth Group has announced a quarterly dividend of $2.21 per share, representing an annualized yield of 2.9%, payable on September 23rd.

GM Advisory Group LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 16.4% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 6,680 shares of the healthcare conglomerate's stock after selling 1,311 shares during the quarter. GM Advisory Group LLC's holdings in UnitedHealth Group were worth $3,499,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the business. Brighton Jones LLC grew its stake in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after acquiring an additional 28,231 shares during the period. Revolve Wealth Partners LLC grew its stake in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after acquiring an additional 2,324 shares during the period. J. Safra Sarasin Holding AG grew its stake in UnitedHealth Group by 20.8% in the fourth quarter. J. Safra Sarasin Holding AG now owns 18,406 shares of the healthcare conglomerate's stock valued at $9,311,000 after acquiring an additional 3,163 shares during the period. Thunderbird Partners LLP boosted its position in shares of UnitedHealth Group by 23.3% during the fourth quarter. Thunderbird Partners LLP now owns 68,116 shares of the healthcare conglomerate's stock valued at $34,457,000 after buying an additional 12,857 shares during the last quarter. Finally, SRS Investment Management LLC boosted its position in shares of UnitedHealth Group by 20.8% during the fourth quarter. SRS Investment Management LLC now owns 291,979 shares of the healthcare conglomerate's stock valued at $147,700,000 after buying an additional 50,286 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.28% of the stock is currently owned by insiders.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $303.77 on Wednesday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The firm has a market cap of $275.12 billion, a price-to-earnings ratio of 13.16, a PEG ratio of 1.99 and a beta of 0.43. The business's fifty day moving average is $289.03 and its 200 day moving average is $393.55.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 earnings per share. The business's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's payout ratio is presently 38.30%.

Analyst Ratings Changes

Several research analysts recently issued reports on UNH shares. TD Securities reaffirmed a "hold" rating and set a $308.00 target price (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Oppenheimer cut their target price on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. JPMorgan Chase & Co. cut their target price on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 6th. Barclays reiterated an "overweight" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Finally, KeyCorp dropped their price target on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Fifteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $367.71.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.